Abstract
Drugs that decrease the activity of one of the chemical messengers in the brain, norpeinephrine, are sometimes helpful for patients with autism-related conditions, or autism spectrum disorders (ASD). Individuals with ASD have decreased flexibility in verbal problem solving. Activity of the norepinephrine system affects performance on such verbal problem solving tasks in individuals without neurodevelopmental diagnoses in experiments using the norepinephrine beta-receptor blocker, propranolol. In individuals without neurodevelopmental diagnoses, response to propranolol depends on how hard the task is, and it is beneficial only for difficult problems. However, in other types of patients with altered norepinephrine or altered flexibility in thinking such as individuals under stress, patients with language loss due to stroke, and individuals in cocaine withdrawal, propranolol also benefits performance for simple problems. Due to decreased flexibility in verbal problem solving in ASD, preliminary evidence suggests that they also respond more favorably to propranolol for simple problems. Future research will be necessary to determine how this cognitive response relates to the clinical response to these agents to better determine if this is a potential mechanism for treatment in ASD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alexander JK, Hillier A, Smith RM, Tivarus ME, Beversdorf DQ (2007) Noradrenergic modulation of cognitive flexibility during stress. J Cogn Neurosci 19:468–478.
American Psychological Association (1995) Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). American Psychological Association, Washington, DC.
Arnsten AF, Goldman-Rakic PS (1984) Selective prefrontal cortical projections to the region of the locus coeruleus and raphe nuclei in the rhesus monkey. Brain Res 306:9–18.
Aston-Jones G, Cohen JD (2005) An integrative theory of locus coeruleus-norpeinephrine function: adaptive gain and optimal performance. Ann Rev Neurosci 28:403–450.
Barnes CA, Pompeiano M (1991) Neurobiology of the locus coeruleus. Prog Brain Res 88:307–321.
Baron-Cohen S, Leslie AM, Frith U (1985) Does the autistic child have a ‘theory of mind’? Cognition 21:37–46.
Barthelemy C, Bruneau N, Cottet-Eymard JM, Domenech-Jouve J, Garreau B, Lelord G, Muh JP, Peyrin L (1988) Urinary free and conjugated catecholamines and metabolites in autistic children. J Autism Devel Disord 18:583–591.
Belmonte MK, Allen G, Beckel-Mitchener A, Boulanger LM, Carper RA, Webb SJ (2004) Autism and abnormal development of brain connectivity. J Neurosci 24:9228–9231.
Beversdorf DQ, Anderson JM, Manning SE, Anderson SL, Nordgren RE, Felopulos GJ, Nadeau SE, Heilman KM, Bauman ML (1998) The effect of semantic and emotional context on written recall for verbal language in high functioning adults with autism spectrum disorder. J Neurol Neurosurg Psychiatry 65:685–692.
Beversdorf DQ, Carpenter AL, Miller RF, Cios JS, Hillier A (2008) Effect of propranolol on verbal problem solving in autism spectrum disorder. Neurocase 14:378–383.
Beversdorf DQ, Hughes JH, Steinberg BA, Lewis LD, Heilman KM (1999) Noradrenergic modulation of cognitive flexibility in problem solving. NeuroReport 10:2763–2767.
Beversdorf DQ, Narayanan A, Hillier A, Hughes JD (2007a) Network model of decreased context utilization in autism spectrum disorder. J Autism Devel Disord 37:1040–1048.
Beversdorf DQ, Sharma UK, Phillips NN, Notestine MA, Slivka AP, Friedman NM, Schneider SL, Nagaraja HN, Hillier A (2007b) Effect of propranolol on naming in chronic Broca’s aphasia with anomia. Neurocase 13:256–259.
Beversdorf DQ, Smith BW, Crucian GP, Anderson JM, Keillor JM, Barrett AM, Hughes JD, Felopulos GJ, Bauman ML, Nadeau SE, Heilman KM (2000) Increased discrimination of “false memories” in autism spectrum disorder. Proc Natl Acad Sci USA 97:8734–8737.
Beversdorf DQ, White DM, Cheever DC, Hughes JD, Bornstein RA (2002) Central beta-adrenergic blockers modulation of cognitive flexibility. NeuroReport 13:2505–2507.
Bowler DM, Gardiner JM, Grice SJ, Saavalainen P (2000) Memory illusions: False recall and recognition in adults with Asperger’s syndrome. J Abnorm Psychol 10:663–672.
Campbell HL, Tivarus ME, Hillier A, Beversdorf DQ (2008) Increased task difficulty results in greater impact of noradrenergic modulation of cognitive flexibility. Pharmacol Biochem Behav 88:222–229.
Chamberlain SR, Müller U, Blackwell AD, Clark L, Robbins TW, Sahakian B (2006a) Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311:861–863.
Chamberlain SR, Müller U, Blackwell AD, Robbins TW, Sahakian B (2006b) Noradrenergic modulation of working memory and emotional memory in humans. Psychopharmacol 188:397–407.
Cohen IL (1994) An artificial neural network analogue of learning in autism. Biol Psychiatry 36:5–20.
Coull JT, Frith CD, Dolan RJ, Frackowiak RSJ, Grasby PM (1997) The neural correlates of the noradrenergic modulation of human attention, arousal and learning. Eur J Neurosci 9:589–598.
Coull JT, Jones MEP, Egan TD, Frith CD, Maze M (2004) Attentional effects of noradrenaline vary with arousal level: selective activation of thalamic pulvinar in humans. NeuroImage 22:315–322.
Curran LK, Newschaffer CJ, Lee L, Crawford SO, Johnston MV, Zimmerman AW (2007). Behaviors associated with fever in children with autism spectrum disorders. Pediatrics 120:e1386–e1392.
Dey MK (1978) Anagram solution speed as a joint function of manifest anxiety and number of category sets. Am J Psychology 91:81–88.
Duncan J, Burgess P, Emslie H (1995) Fluid intelligence after frontal lobe lesions. Neuropsychologia 33:261–268.
Eslinger PJ, Grattan LM (1993) Frontal lobe and frontal-striatal substrates for different forms of human cognitive flexibility. Neuropsychologia 31:17–28.
Faigel HC (1991) The effect of beta blockade on stress-induced cognitive dysfunction in adolescents. Clin Pediatrics 30:441–445.
Fankhauser MP, Karumanchi VC, German ML, Yates A, Karumanchi SD (1992) A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. J Clin Psychiatry 53:77–82.
Foster DJ, Good DC, Fowlkes A, Sawaki L (2006) Atomoxetine enhances a short-term model of plasticity in humans. Arch Phys Med Rehabil 87:216–221.
Fotheringham JB (1991) Autism: Its primary psychological and neurological deficit. Can J Psychiatry 36:686–692.
Frith U, Happé FGE (1994) Autism: beyond theory of mind. Cognition 50:115–132.
Ghacibeh GA, Shenker JI, Shenal B, Uthman BM, Heilman KM (2006) Effect of vagus nerve stimulation on creativity and cognitive flexibility. Epilepsy Behav 8:720–725.
Guilford JP (1967) The Nature of Human Intelligence. McGraw-Hill, New York.
Happé FGE (1994) An advanced test of theory of mind: understanding of story characters’ thoughts and feelings by able autistic, mentally handicapped, and normal children and adults. J Autism Devel Disord 24:129–154.
Harleston BW, Smith MG, Arey D (1965) Test-anxiety level, heart rate, and anagram problem solving. J Person Soc Psychol 1:551–557.
Hasselmo ME, Linster C, Patil M, Ma D, Cecik M (1997) Noradrenergic suppression of synaptic transmission may influence cortical signal-to-noise ratio. J Neurophysiol 77 3326–3339.
Heaton RK (1981) Wisconsin Card Sort Test Manual. Odessa, FL: Psychological Assessment Resources.
Hermelin B, Frith U (1991) Psychological studies of childhood autism: can autistic children make sense of what they hear? Focus on Autistic Behavior 6:6–13.
Hermelin B, O’Connor N (1970) Psychological experiments with autistic children. Oxford: Oxford University Press.
Hillier A, Campbell H, Keillor J, Phillips N, Beversdorf DQ (2007) Decreased false memory for visually presented shapes and symbols among adults on the autism spectrum. J Clin Exp Neuropsychol 29:610–616.
Hobson RP (1991) Methodological issues for experiments on autistic individuals’ perception and understanding of emotion. J Child Psychol Psychiatry 32:1135–1158.
Hobson RP (1993) Understanding persons: the role of affect. In S Baron-Cohen, H Tager-Flusberg, DJ Cohen (Eds), Understanding other minds: perspectives from autism. Oxford University Press, Oxford, pp. 208–227.
Jaselskis CA, Cook EH Jr, Fletcher KE, Leventhal BL (1992) Clonidine treatment of hyperactive and impulsive children with autistic disorder. J Clin Psychopharmacol 12:322–327.
Just MA, Cherkassky VL, Keller TA, Kana RK, Minshew NJ (2007) Functional and anatomical cortical underconnectivity in autism: evidence from an fMRI study of an executive function task and corpus callosum morphometry. Cerebral Cortex 17:951–961.
Just MA, Cherkassky VL, Keller TA, Minshew NJ (2004) Cortical activation and synchronization during sentence comprehension in high-functioning autism: evidence of underconnectivity. Brain 127:1811–1821.
Karnath HO, Wallesch CW (1992) Inflexibility of mental planning: a characteristic disorder with prefrontal lobe lesions. Neuropsychologia 30:1011–1016.
Kelley BJ, Yeager KR, Pepper TH, Bornstein RA, Beversdorf DQ (2007) The effect of propranolol on cognitive flexibility and memory in acute cocaine withdrawal. Neurocase 13:320–327.
Koshes RJ, Rock NL (1994) Use of clonidine for behavioral control in an adult patient with autism. Am J Psychiatry 151:1714.
Kvetnansky R, Pacak K, Sabban EL, Kopin IJ, Goldstein DS (1998) Stressor specificity of peripheral catecholaminergic activation. Adv Pharmacol 42:556–560.
Lader M (1988) Beta-adrenergic antagonists in neuropsychiatry: an update. J Clin Psychiatry 49:213–223.
Lake CR, Ziegler MG, Murphy DL (1977) Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism. Arch Gen Psychiatry 34:553–556.
Lapiz MDS, Morilak DA (2006) Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 137: 1039–1049.
Launay J-M, Bursztejn C, Ferrari P, Dreux C, Braconnier A, Zarifian E, Lancrenon S, Fermanian J (1987) Catecholamines metabolism in infantile autism: a controlled study of 22 autistic children. J Autism Devel Disord 17:333–347.
Laverdue B, Boulenger JP (1991) Medications beta-bloquantes et anxiete. Un interet therapeutique certain. [Beta-blocking drugs and anxiety. A proven therapeutic value.] L’Encephale 17:481–492.
Lipnicki DM, Byrne DG (2005) Thinking on your back: solving anagrams faster when supine than when standing. Cogn Brain Res 24:719–722.
Martchek M, Thevarkunnel S, Bauman M, Blatt G, Kemper T (2006) Lack of evidence of neuropathology in the locus coeruleus in autism. Acta Neuropathologica 111:497–499.
Martindale C Greenough, J (1975) The differential effect of increased arousal on creative and intellectual performance. J Genet Psychol 123:329–335.
Martineau J, Barthelemy C, Jouve J, Muh J-P, Lelord G (1992) Monoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug effects. Devel Med Child Neurol 34:593–603.
McClelland JL (2000) The basis of hyperspecificity in autism: a preliminary suggestion based on properties of neural nets. J Autism Devel Disord 30:497–502.
Mehler MF, Purpura DP (2009) Autism, fever, epigenetics and the locus coeruleus. Brain Res Rev, 59:388–392.
Miller LA, Tippett LJ (1996) Effects of focal brain lesions on visual problem-solving. Neuropsychologia 34:387–398.
Minderaa RB, Anderson GM, Volkmar FR, Akkerhuis GW, Cohen DJ (1994) Noradrenergic and adrenergic functioning in autism. Biol Psychiatry 36:237–241.
Minshew NJ, Goldstein G (2001) The pattern of intact and impaired memory functions in autism. J Child Psychol Psychiatry 42:1095–1101.
Mottron L, Burack JA (2001) Enhanced perceptual functioning in the development of autism. In JA Burack, T Charman, N Yirmiya, PR Zelazo (Eds), The development of autism: Perspectives from theory and research.Lawrence Erlbaum Associates, Mahwah, NJ, pp. 131–148.
O’Connor N, Hermelin B (1967) Auditory and visual memory in autistic and normal children. J Mental Deficiency 11:126–131.
Petsche H (1996) Approaches to verbal, visual and musical creativity by EEG coherence analysis. Int J Psychophysiol 24:145–159.
Ratey JJ, Bemporad J, Sorgi P, Bick P, Polakoff S, O‘Driscoll G, Mikkelsen E (1987) Brief report: open trial effects of beta-blockers on speech and social behaviors in 8 autistic adults. J Autism Devel Disord 17:439–446.
Robbins TW (2007) Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications. Phil Trans Royal Soc London. Series B: Biol Sci 362:917–932.
Rumsey JM, Hamburger SD (1990) Neuropsychological divergence of high-level autism and severe dyslexia. J Autism Devel Disord 20:155–168.
Rumsey JM, Hamburger SD (1988) Neuropsychological findings in high-functioning men with infantile autism, residual state. J Clin Exp Neuropsychol 10:201–221.
Rumsey JM (1985) Conceptual problem-solving in highly verbal, non-retarded autistic men. J Autism Devel Disord 15:23–36.
Scaduto MJ, White CA, Saklayen SS, Narayanan A, Beversdorf DQ (2008) The effect of propranolol on word fluency in autism spectrum disorder. 60th Annual Meeting of the American Academy of Neurology.
Seltzer MM, Krauss MW, Shattuck PT, Orsmond G, Swe A, Lord C (2003) The symptoms of autism spectrum disorders in adolescence and adulthood. J Autism Devel Disord 33:565–581.
Smith A, Nutt D (1996) Noradrenaline and attention lapses. Nature 380:291.
Stickgold R, Hobson JA, Fosse R, Fosse M (2001) Sleep, learning, and dreams: off-line memory reprocessing. Science 294:1052–1057.
Thyer BA, Papsdorf JD (1982) Discriminant and concurrent validity of two commonly used measures of test anxiety. Educ Psychol Meas 42:1197–1204.
Tomasini J (1973) Effect of peer-induced anxiety on a problem-solving task. Psychol Rep 33:355–358.
Usher M, Cohen JD, Servan-Schreiber D, Rajkowski J, Aston-Jones G (1999) The role of locus coeruleus in the regulation of cognitive performance. Science 283:549–554.
Vikki J (1992) Cognitive flexibility and mental programming after closed head injuries and anterior and posterior cerebral excisions. Neuropsychologia 30:807–814.
Ward MM, Metford IN, Parker SD, Chesney MA, Taylor CB, Keegan DL, Barchas JD (1983) Epinephrine and norepinephrine responses in continuously collected human plasma to a series of stressors. Psychosomat Med 45:471–486.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Beversdorf, D.Q. (2010). The Role of the Noradrenergic System in Autism Spectrum Disorders. In: Blatt, G.J. (eds) The Neurochemical Basis of Autism. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-1272-5_11
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1272-5_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-1271-8
Online ISBN: 978-1-4419-1272-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)